Brief: Biomed Lublin Says Partner's Offer Chosen In Tender For Tuberculosis Vaccine
Dec 21 (Reuters) - Biomed Lublin Wytwornia Surowic i
Szczepionek SA BML.WA :
* SAYS POLAND'S HEALTH MINISTRY PROCUREMENT OFFICE CHOOSES
OFFER
OF COMPANY'S TRADE PARTNER
* SAYS CHOSEN OFFER REGARDS TENDER FOR TUBERCULOSIS VACCINE
* SAYS TENDER PARTNER OFFERED BCG 10 TUBERCULOSIS VACCINE
PRODUCED
BY COMPANY
* SAYS TUBERCULOSIS VACCINES OF TOTAL VALUE 7.3 MILLION
ZLOTYS ARE
TO BE DELIVERED UNDER TENDER
Source text for Eikon: ID:nEM6NTYv7a
Further company coverage: BML.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility